Full Year Results - 12 August 2015
Join CSL Limited CEO Paul Perreault and CFO Gordon Naylor for a live webcast from 11am
Our Corporate Responsibility 2014
View Our Corporate Responsibility 2014
CSL Supports New Medical Research Future Fund
CSL is strongly supportive of the new fund and ...
Australia’s Innovation System Could Deliver More
CSL outlined two strategic reforms that could ...
CSL completes Novartis influenza vaccine business acquisition
The combined business will create the second ...
Update on Novartis influenza vaccines acquisition
CSL has secured the necessary approvals required ...